| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |